Skip to content

A study for the effect of the intake of an aojiru beverage on microflora

A study for the effect of the intake of an aojiru beverage on microflora - A study for the effect of the intake of an aojiru beverage on microflora

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025249
Enrollment
20
Registered
2016-12-13
Start date
2016-12-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rough skin, dry skin

Interventions

Ingestion of an aojiru bevarage twice a day for 8weeks Ingestion of a placebo bevarage twice a day for 8weeks

Sponsors

TOYO SHINYAKU Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Healthy female 20 years of age or more 2.Subjects who have rough skin by drying or other skin problems 3.Subjects who can make self-judgement and are voluntarily giving written informed consents 4.Subjects who can obey the directions of the investigators

Exclusion criteria

Exclusion criteria: 1.Subjects who take antibiotics within the last two months prior to the current study or who take intestinal drugs daily 2.Subjects who are under treatment by a dermatologist for dry skin, inflammation or other skin diseases. Or difficulty with measuring points by scars or other skin problems 3.Subjects who are serious constipated or contract serious diseases of anus or intestines 4.Subjects who contract diseases which may affect the current study 5.Subjects who are menstrual irregularity (except for menopause) 6.Subjects who take other aojiru, foods which influence intestinal functions, supplements, other specified foods daily, and they are not able to stop during the current study period 7.Subjects who have declared allergic reaction to test foods 8.Subjects who are under treatment for or have a history of drug addiction or alcoholism 9.Subjects who are pregnant or are planning to become pregnant after informed consent for the current study 10.Subjects who are planning to participate and/or are participating in other clinical studies 11.Subjects who are judged as unsuitable for the current study by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Measurement of skin conditions (measurement time: 0,4,8 weeks after ingestion of the test bevarage) Measurement of microflora (measurement time: 0,8 weeks after ingestion of the test bevarage)

Countries

Japan

Contacts

Public ContactKusaba Nobutaka

TOYO SHINYAKU Co., Ltd. Research Promotion Office

gakujutsu@toyoshinyaku.co.jp0942-81-3555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026